Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


RSV OR THE FLU? NOW YOU KNOW IT IMMEDIATELY

Janssen Diagnostics has developed a molecular diagnostic test which will be used with the Biocartis’ Idylla™ platform, to determine Influenza and …


Ebola diagnostics – faster, safer, and more accurate

“Last year the Ebola outbreak kick-started the development of a fast and accurate Ebola test to be used with Biocartis’ Idylla™ platform” - says D…

POPULAR TAGS

Roche acquires Biocartis’ competitor

Written by DS on in the category news with the tags , , .


Roche has paid 190 million dollar for the acquisition of GeneWEAVE (Los Gatos, CA), an American company that specializes in molecular diagnostics. GeneWEAVE’s shareholders even can receive 235 million dollar more in milestone payments.

GeneWEAVE’s first system in development is the vivoDx—a fully automated, random-access system designed to rapidly recognize multidrug-resistant organisms. It quickly identifies the bacteria attacking a patient and which antibiotics are suitable to treat the patient. This is done directly on clinical samples, without the need for traditional enrichment, culture or sample preparation processes, which leads to fast results. For example in the case of sepsis, where rapid diagnosis is crucial, this can be of major importance. One in two patient dies, but this number may drop significantly if the right treatment is started immediately.

Biocartis (Mechelen) also aims at bringing a similar test on the market to use with its automated diagnostic platform, Idylla, by 2017.

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


RSV OR THE FLU? NOW YOU KNOW IT IMMEDIATELY

Janssen Diagnostics has developed a molecular diagnostic test which will be used with the Biocartis’ Idylla™ platform, to determine Influenza and …


Ebola diagnostics – faster, safer, and more accurate

“Last year the Ebola outbreak kick-started the development of a fast and accurate Ebola test to be used with Biocartis’ Idylla™ platform” - says D…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

XpandInnovation V-Bio Ventures Flanders.bio Janssen Biowin KU Leuven UGent Itera Life Science Turnstone GSK

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.